
|Articles|April 20, 2022
Daily Medication Pearl: Haloperidol (Haldol)
Author(s)Saro Arakelians, PharmD
Haloperidol (Haldol) is indicated for use in the treatment of schizophrenia and to control the symptoms of Tourette's disorder, as well as severe behavioral problems or hyperactivity in children.
Advertisement
Medication Pearl of the Day: Haloperidol (Haldol)
Indication: Haloperidol (Haldol) is indicated for use in the treatment of schizophrenia and is indicated to control the symptoms of Tourette's disorder. Haloperidol may also used to treat severe behavioral problems or hyperactivity in children unsuccessfully treated with psychotherapy or other medicines.
Insight:
- Dosing: The initial dose of haloperidol decanoate should not exceed 100 mg regardless of previous antipsychotic dose requirements– see package insert
- Dosage forms: 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg, 2 mg/ml, 5 mg/ml, 50 mg/ml.
- Adverse events: Neurologic symptoms, cardiovascular effects, leukopenia, neutropenia, and agranulocytosis.
- Mechanism of action: Mechanism of action is unknown. The active mechanism is to block postsynaptic dopamine receptors in the mesolimbic system of the brain.
- Manufacturer:Upsher-Smith Laboratories
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























